The U.S. Food and Drug Administration (FDA) has approved bemotrizinol for use in sunscreens, marking the first time in 27 years the agency has cleared a new chemical UV filter. This ingredient, which blocks both UVA and UVB rays while remaining photostable, is expected to reach American retail shelves by September under the brand name Parsol Shield. According to Dr. Heather Rogers, a Seattle-based dermatologist, the approval addresses long-standing limitations in domestic sunscreen technology by providing high-level protection without the cosmetic drawbacks of traditional mineral filters.
Why does the FDA approval of bemotrizinol matter for consumers?
For decades, American consumers have faced a trade-off between effective chemical protection and the aesthetic quality of their sunscreen. According to Kelly Dobos, a cosmetic chemist at the University of Cincinnati, current U.S. chemical sunscreens rely heavily on avobenzone to block UVA rays. Unlike bemotrizinol, avobenzone is not photostable and degrades rapidly upon sun exposure, potentially releasing irritating molecules. Bemotrizinol maintains its integrity under light, ensuring that protection does not diminish significantly during the recommended two-hour application window, says Dr. Rogers.
How does this new filter change the appearance of sunscreen?
The primary alternative to chemical filters has been mineral-based zinc oxide or titanium dioxide. While effective, these ingredients often leave a visible white or “ashy” residue on the skin. Dr. Rogers notes that this “white cast” is a significant barrier to daily use, particularly for people of color. Because bemotrizinol is transparent and highly efficient, it requires fewer auxiliary stabilizing ingredients. This shift allows formulators to create sunscreens that are less greasy and more aesthetically pleasing, which cosmetic chemist Kelly Dobos suggests will likely increase consumer compliance and public health outcomes.
What is the safety profile of the new ingredient?
Bemotrizinol has been in use in Europe and Asia for decades, providing a deep reservoir of safety data. Alexa Friedman, a senior scientist with the Environmental Working Group (EWG), states that the ingredient has undergone rigorous testing, including clinical human trials that show it does not irritate the skin, even with repeated use. Furthermore, because the molecules of bemotrizinol are larger than those of other chemical filters, it is not readily absorbed into the bloodstream. This distinction is significant, as concerns regarding systemic absorption of older chemical filters have fueled public skepticism and social media misinformation about sunscreen safety.
Comparison: Old vs. New UV Filters
| Feature | Traditional Chemical Filters | Bemotrizinol |
|---|---|---|
| Photostability | Low (breaks down) | High |
| Skin Finish | Transparent | Transparent |
| Absorption | Higher | Minimal |
Frequently Asked Questions
When will sunscreens with bemotrizinol be available?
Products containing the ingredient, marketed as Parsol Shield, are expected to reach store shelves in the United States starting in September.
Is bemotrizinol better than zinc oxide?
Both are effective, but bemotrizinol offers a transparent, non-greasy finish that avoids the white cast often associated with mineral sunscreens, making it a preferred choice for many skin tones.
Is this ingredient safe for long-term use?
Yes, according to the Environmental Working Group, bemotrizinol has a well-documented safety profile with clinical data showing it does not cause reproductive harm or skin irritation.
Have you struggled to find a sunscreen that doesn’t leave a white cast or irritate your skin? Share your experience in the comments below or subscribe to our newsletter for the latest updates on dermatological health and product innovations.
